General Information of Disease (ID: DISSOMMH)

Disease Name Carbamoyl phosphate synthetase I deficiency disease
Synonyms
hyperammonemia due to carbamoyl phosphate synthetase 1 deficiency; carbamoyl phosphate synthetase 1 deficiency, hyperammonemia due to; carbamoyl phosphate synthetase 1 deficiency; carbamyl phosphate synthetase (CPS) deficiency; carbamoyl phosphate synthetase I deficiency, hyperammonemia due to; CPS 1 deficiency; carbamoyl-phosphate synthetase 1 deficiency; carbamoyl-phosphate synthetase I deficiency; carbamoyl phosphate synthetase I deficiency disease; carbamoylphosphate synthetase I deficiency; CPS1D; CPS I deficiency; carbamoyl-phosphate synthase deficiency disease; carbamoyl phosphate synthetase deficiency; carbamoyl-phosphate synthetase deficiency; CPS1 deficiency
Definition
Carbamoyl-phosphate synthetase 1 deficiency (CPS1D) is a rare and severe disorder of urea cycle metabolism most commonly characterized by either a neonatal-onset of severe hyperammonemia that occurs few days after birth and manifests with lethargy, vomiting, hypothermia, seizures, coma and death or a presentation outside the newborn period at any age with (sometimes) milder symptoms of hyperammonemia.
Disease Hierarchy
DISKD7HM: Urea cycle disorder or inherited hyperammonemia
DISSOMMH: Carbamoyl phosphate synthetase I deficiency disease
Disease Identifiers
MONDO ID
MONDO_0009376
MESH ID
D020165
UMLS CUI
C4082171
OMIM ID
237300
MedGen ID
907954
Orphanet ID
147

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 2 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
CPS1 TT42M75 Limited Altered Expression [1]
CPS1 TT42M75 Definitive Autosomal recessive [2]
------------------------------------------------------------------------------------
This Disease Is Related to 2 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ASL OTI2NGQR Strong Genetic Variation [3]
CPS1 OTXV8NSR Definitive Autosomal recessive [2]
------------------------------------------------------------------------------------

References

1 Conditional disruption of hepatic carbamoyl phosphate synthetase 1 in mice results in hyperammonemia without orotic aciduria and can be corrected by liver-directed gene therapy.Mol Genet Metab. 2018 Aug;124(4):243-253. doi: 10.1016/j.ymgme.2018.04.001. Epub 2018 Apr 12.
2 Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.
3 Hereditary urea cycle diseases in Finland.Acta Paediatr. 2008 Oct;97(10):1412-9. doi: 10.1111/j.1651-2227.2008.00923.x. Epub 2008 Jul 9.